SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...
SAN ANTONIO, January 22, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage ...
SAN ANTONIO, July 29, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today shared ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, ...
SAN ANTONIO, October 30, 2024--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage ...
With a San Antonio biotech firm’s test, your phlegm could help save you from cancer. The screening method developed by bioAffinity Technologies Inc. uses AI-aided computer analysis of a patient’s ...
A 5-second finger test can help detect early signs of lung cancer. The test involves pressing your thumbnails together. If a diamond shape does not form, it may indicate finger clubbing. Clubbing can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results